Innate Pharma

-$0.09 (-2.20%) Today
+$0.50 (+12.47%) As of 9:25 PM UTC after-hours

Why Robinhood?

You can watch Innate Pharma and buy or sell other stocks, options, and ETFs commission-free!

About IPHA

Innate Pharma S.A. ADS, also called Innate Pharma, is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

CEO
Mondher Mahjoubi
Employees
237
Headquarters
Marseille, Provence-Alpes-Cote-dAzur
Founded
1999

IPHA Key Statistics

Market Cap
316.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
36.60K
High Today
$4.22
Low Today
$3.97
Open Price
$4.22
Volume
12.28K
52 Week High
$7.50
52 Week Low
$3.55

IPHA Earnings

Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Sep 15
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure